Life Science Investing IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
Life Science Investing IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer
Life Science Investing Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
